Illumina, Inc. (ILMN)
239.62
-5.56
(-2.27%)
USD |
NASDAQ |
Sep 18, 16:00
240.11
+0.49
(+0.20%)
After-Hours: 20:00
Illumina Research and Development Expense (TTM) : 963.00M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 963.00M |
| March 31, 2026 | 949.00M |
| December 31, 2025 | 950.00M |
| September 30, 2025 | 967.00M |
| June 30, 2025 | 991.00M |
| March 31, 2025 | 1.073B |
| December 31, 2024 | 1.17B |
| September 30, 2024 | 1.244B |
| June 30, 2024 | 1.307B |
| March 31, 2024 | 1.34B |
| December 31, 2023 | 1.343B |
| September 30, 2023 | 1.353B |
| June 30, 2023 | 1.363B |
| March 31, 2023 | 1.332B |
| December 31, 2022 | 1.314B |
| September 30, 2022 | 1.325B |
| June 30, 2022 | 1.436B |
| March 31, 2022 | 1.311B |
| December 31, 2021 | 1.185B |
| September 30, 2021 | 1.035B |
| June 30, 2021 | 771.00M |
| March 31, 2021 | 724.00M |
| December 31, 2020 | 683.00M |
| September 30, 2020 | 644.00M |
| June 30, 2020 | 623.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 634.00M |
| December 31, 2019 | 647.00M |
| September 30, 2019 | 662.00M |
| June 30, 2019 | 670.00M |
| March 31, 2019 | 655.00M |
| December 31, 2018 | 623.00M |
| September 30, 2018 | 584.00M |
| June 30, 2018 | 559.00M |
| March 31, 2018 | 538.00M |
| December 31, 2017 | 541.00M |
| September 30, 2017 | 533.92M |
| June 30, 2017 | 525.83M |
| March 31, 2017 | 520.42M |
| December 31, 2016 | 504.42M |
| September 30, 2016 | 488.85M |
| June 30, 2016 | 462.16M |
| March 31, 2016 | 433.75M |
| December 31, 2015 | 401.53M |
| September 30, 2015 | 380.89M |
| June 30, 2015 | 366.25M |
| March 31, 2015 | 352.56M |
| December 31, 2014 | 337.75M |
| September 30, 2014 | 320.65M |
| June 30, 2014 | 306.91M |
| March 31, 2014 | 292.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.403B |
| Agilent Technologies, Inc. | 480.00M |
| Danaher Corp. | 1.615B |
| Pacific Biosciences of California, Inc. | 92.16M |
| Bio-Rad Laboratories, Inc. | 260.70M |